Two Sigma Securities’s AIM ImmunoTech AIM Stock Holding History
Bought
Maintained
Sold
Other funds holding AIM
CB
HI
HI
DB
Two Sigma Securities's AIM Position: Q2 2025 in Review
Two Sigma Securities sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 207 shares — an estimated $2.53K sold.
Two Sigma Securities first reported a position in AIM in Q4 2015 and held it in 14 quarters. The position peaked at $46.6K in Q2 2024. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.
- Two Sigma Securities reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
- Two Sigma Securities sold 207 AIM ImmunoTech shares in Q2 2025, an estimated $2.53K.
- Two Sigma Securities first reported a position in AIM ImmunoTech in Q4 2015 and held it in 14 quarters.
- Two Sigma Securities's AIM ImmunoTech position peaked at $46.6K in Q2 2024.
- 12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.
Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.